Other
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)
AbbVie AOCI - Cash Flow Hedge Reclassification (Next 12 Months) increased by 102.8% to $1.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ3 2018
Last reportedQ1 2026May 8, 2026
Metric ID:
aoci_cash_flow_hedge_reclassification_12mHistorical Data
4 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $105.00M | -$8.00M | -$36.00M | $1.00M |
| QoQ Change | — | -107.6% | -350.0% | +102.8% |
| YoY Change | — | — | — | -99.0% |
Range-$36.00M – $105.00M
Avg YoY Growth-99.0%
Median YoY Growth-99.0%
AOCI - Cash Flow Hedge Reclassification (Next 12 Months) at Other Companies
Frequently Asked Questions
- What is AbbVie's aoci - cash flow hedge reclassification (next 12 months)?
- AbbVie (ABBV) reported aoci - cash flow hedge reclassification (next 12 months) of $1.00M in Q1 2026.